2 Stocks That Could Soar Again in 2025
Viking Therapeutics got the market's attention with robust phase 2 results for VK2735, a potential weight loss therapy.
Analysts Predict Up to ~450% Surge for These 2 ‘Strong Buy’ Penny Stocks
Some of the market’s biggest winners start off as the smallest players. While trillion-dollar tech giants like the ...
Down 65%, Is Viking Therapeutics Stock a Buy on the Dip?
Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results ...
Terns Pharma: I Don't See The Positioning
Terns Pharmaceuticals' TERN-701 and TERN-601 face challenges in CML and obesity. Find out why TERN stock is not a strong buy amid tough competition.
TOP RANKED ROSEN LAW FIRM Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BIOA
Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of BioAge Labs, Inc. (NASDAQ:BIOA) pursuant and/or traceable to BioAge's registration statement for the initial public ...